New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 4, 2014
09:17 EDTAMGN, ESRXAmgen to see minimal impact from coverage changes, says RBC Capital
RBC Capital believes that Express Scripts' (ESRX) decision to refrain from covering Epo and Aranesp in 2015 will have minimal impact on Amgen (AMGN). The firm thinks Express Scripts' decision may have caused Amgen's stock to be weak versus its peers on Friday. The firm keeps an Outperform rating on Amgen.
News For AMGN;ESRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
June 30, 2015
11:36 EDTAMGNRumor: Amgen moves up on speculation of an investor stake
Subscribe for More Information
07:03 EDTAMGNCelgene leaps forward in immuno-oncology with Juno deal, says Piper Jaffray
Piper Jaffray analyst Joshua Schimmer said that Celgene (CELG) effectively spent $1B to buy into adoptive T cell therapy and own all of Juno Therapeutics' (JUNO) opportunities outside the U.S., leaping the company into a leading position in the immuno-oncology space. Schimmer additionally thinks Celgene's transaction should help boost investor confidence about the utility and value of CAR and TCR therapies, noting that he sees Bellicum Pharmaceuticals (BLCM), Cellectis (CLLS), Lion Biotechnologies (LBIO), bluebird bio (BLUE) and the Amgen (AMGN)-Kite Pharma (KITE) partnership as best positioned to compete in this rapidly advancing field. The analyst keeps an Overweight rating and $144 price target on Celgene.
June 29, 2015
11:21 EDTESRXMorgan Stanley reports 5% passive stake in Express Scripts
Subscribe for More Information
June 25, 2015
05:48 EDTESRXStocks with implied volatility movement; SDS ESRX
Stocks with implied volatility movement; UltraShort S&P500 ProShares (SDS) 28, Express Scripts (ESRX) 27 according to iVolatility.
June 24, 2015
14:13 EDTESRXExpress Scripts July weekly volatility elevated as shares near record high
Subscribe for More Information
07:56 EDTAMGNAmgen management to meet with Evercore ISI
Subscribe for More Information
June 23, 2015
07:25 EDTAMGNPiper Jaffray to hold a summit
2015 Piper Jaffray Heartland Summit is being held in Minneapolis on June 23-24.
June 22, 2015
08:16 EDTESRXAnthem, Cigna deal would be negative for Catamaran, says Leerink
Subscribe for More Information
June 19, 2015
16:02 EDTAMGNAmgen presents open-label extension data for Phase 2 study of migraine treatment
Subscribe for More Information
11:17 EDTESRXExpress Scripts calls active amid bid speculation
Subscribe for More Information
07:23 EDTAMGNTeva data quite strong, says Bernstein
After Teva (TEVA) announced data for its TEV-48125 drug in episodic migraine, Bernstein notes that the drug met its primary and secondary endpoints. The firm says that the reduction in migraine days of Teva's drug appears to be higher than what Amgen (AMGN) and Lilly (LLY) have shown. The firm continues to see the migraine treatments from Teva and Alder as better than those from Lilly and Amgen.
June 18, 2015
16:06 EDTAMGNAmgen says Phase 3 trial of Vectibix met primary endpoint
Subscribe for More Information
10:01 EDTESRXOn The Fly: Analyst Initiation Summary
Subscribe for More Information
07:38 EDTESRXLeerink to hold a roundtable
Subscribe for More Information
June 17, 2015
16:20 EDTESRXExpress Scripts initiated with a Perform at Oppenheimer
Subscribe for More Information
09:43 EDTESRXExpress Scripts management to meet with Deutsche Bank
Meeting to be held in New York on June 17 hosted by Deutsche Bank.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use